Evidence map›Paper›PMID 24753150›Full record

ReviewMagnetic resonance in medicine2015

Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking.

Erik M Shapiro

Abstract readReview
In one paragraph

Review in Magnetic resonance in medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. MRI techniques for immunotherapy monitoring.Journal for immunotherapy of cancer · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Erik M ShapiroDepartment of Radiology, Michigan State University, East Lansing, Michigan, USA.

Funding

Single cell MRI of directed cell migration to strokeDP2OD004362 · OD · YALE UNIVERSITY · PI SHAPIRO, ERIK · 2008 to 2008
$2.5M
MRI-based immune cell tracking in Alzheimer?s diseaseR21AG041266 · NIA · YALE UNIVERSITY · PI SHAPIRO, ERIK · 2011 to 2012
$435k
NIA NIH HHS R21 AG041266NIH HHS DP2 OD004362
6 · The paper itself

Abstract

Metallic particles have shaped the use of magnetic resonance imaging (MRI) for molecular and cellular imaging. Although these particles have generally been developed for extracellular residence, either as blood pool contrast agents or targeted contrast agents, the coopted use of these particles for intracellular labeling has grown over the last 20 years. Coincident with this growth has been the development of metal oxide particles specifically intended for intracellular residence, and innovations in the nature of the metallic core. One promising nanoparticle construct for MRI-based cell tracking is polymer encapsulated metal oxide nanoparticles. Rather than a polymer coated metal oxide nanocrystal of the core: shell type, polymer encapsulated metal oxide nanoparticles cluster many nanocrystals within a polymer matrix. This nanoparticle composite more efficiently packages inorganic nanocrystals, affording the ability to label cells with more inorganic material. Further, for magnetic nanocrystals, the clustering of multiple magnetic nanocrystals within a single nanoparticle enhances r2 and r2* relaxivity. Methods for fabricating polymer encapsulated metal oxide nanoparticles are facile, yielding both varied compositions and synthetic approaches. This review presents a brief history into the use of metal oxide particles for MRI-based cell tracking and details the development and use of biodegradable, polymer encapsulated, metal oxide nanoparticles and microparticles for MRI-based cell tracking.

Indexed as

Absorbable ImplantsAnimalsCell TrackingContrast MediaDrug ImplantsHumansImage EnhancementMagnetic Resonance ImagingMetal NanoparticlesPolymersReproducibility of ResultsSensitivity and SpecificityContrast MediaDrug ImplantsPolymersMRI; particles; stem cells; iron oxide; polymer

Identifiers

PMID24753150
PMCPMC4336226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.